Retour à la liste des essais cliniquesENT/Head and Neck Cancers

Nanoray-312

A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With LA-HNSCC

Ouvert à Paris depuis le : 18/02/2022
Public cible : Adult
Phase : Phase III

Description de l'essai

This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy/performance and safety of NBTXR3/RT±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with LA-HNSCC

Url of the trial

Investigateur principal

MARIA LESNIK

Médecin

Contacter